Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. [electronic resource]
Producer: 20130311Description: 407-13 p. digitalISSN:- 1524-4628
- Aged
- Aged, 80 and over
- Brain Ischemia -- drug therapy
- Endovascular Procedures -- methods
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Reperfusion -- trends
- Retrospective Studies
- Smoking -- adverse effects
- Stroke -- drug therapy
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.